Triple-negative breast cancer (TNBC) is a coalition of diverse breast cancers only unified by the common feature of lacking expression of hormone receptors (estrogen and progesterone) and human epidermal growth factor receptor-2 (HER2) (Marra et al., 2020). Here, ERBB2 is linked to triple-negative breast carcinoma.